New diagnostic criteria for multiple sclerosis are helping doctors identify the disease sooner, allowing patients to begin ...
Dr. Daniel Ontaneda, a neurologist with Cleveland Clinic, said more than two dozen approved medications can help control MS ...
Supplementation with high-dose vitamin D for more than one year significantly reduced relapse risk and eased disability in ...
Our latest CPD module explores five common but challenging neurology cases encountered in general practice, and discusses evidence-based approaches to assessment, investigation and management.
Dysphagia, a severe comorbidity of many neurological diseases, often lacks targeted therapies. This critical review assessed ...
Cardiovascular surgery seems to be just as safe in patients with concomitant multiple sclerosis (MS) as in those without the ...
He references the phenomenon called ‘social prescribing’ which is part of the National Health Service in the UK — where an ...
Detailed price information for Tg Therapeutics (TGTX-Q) from The Globe and Mail including charting and trades.
Emily Standley Allard on MSN
Top 10 inspiring women disruptors making waves in 2026
True disruption demands both vision and courage, and these ten remarkable women are leading that charge in 2026.
Precision neurostimulation leverages AI and closed-loop feedback, delivering tailored treatments for neurological disorders ...
MarketBeat on MSN
Adaptive Biotechnologies Highlights clonoSEQ Growth, 2026 Cash Flow Goal at Conference
Adaptive Biotechnologies (NASDAQ:ADPT) Chief Executive Officer and Co-Founder Chad Robins said the company is focused on expanding its minimal residual disease testing business while pursuing targeted ...
The plan's most telling feature is what it left out. Two months before the announcement, Pfizer and Valneva reported that their Lyme vaccine had passed its final major trial, cutting confirmed cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results